Dyslipidemias

Pathophysiology, Evaluation and Management

  • Abhimanyu Garg

Part of the Contemporary Endocrinology book series (COE)

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Daniel J. Rader, Sumeet A. Khetarpal
    Pages 1-12
  3. Peter W.F. Wilson
    Pages 13-24
  4. Byambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang, Lars Berglund
    Pages 25-55
  5. Ravi Dhingra, Ramachandran S. Vasan
    Pages 57-65
  6. Henna Cederberg, Markku Laakso
    Pages 99-113
  7. David M. Maahs, Robert H. Eckel
    Pages 115-135
  8. Frederick J. Lee, Andrew Carr
    Pages 155-176
  9. Fernando Civeira, Miguel Pocovi
    Pages 177-203
  10. Amanda Brahm, Robert A. Hegele
    Pages 205-220
  11. Jessica Sparks Lilley, MacRae F. Linton, Sergio Fazio
    Pages 221-233
  12. Shailendra B. Patel
    Pages 235-250
  13. Amanda J. Hooper, John R. Burnett
    Pages 251-266
  14. Vinaya Simha
    Pages 267-286
  15. Abhimanyu Garg
    Pages 287-302
  16. Scott M. Grundy
    Pages 313-327
  17. Ernst J. Schaefer, Mariko Tani
    Pages 329-341

About this book

Introduction

Dyslipidemias: Pathophysiology, Evaluation and Management provides a wealth of general and detailed guidelines for the clinical evaluation and management of lipid disorders in adults and children.  Covering the full range of common through rare lipid disorders, this timely resource offers targeted, practical information for all clinicians who care for patients with dyslipidemias, including general internists, pediatric and adult endocrinologists, pediatricians, lipidologists, cardiologists, internists, and geneticists.  For the last twenty years, there has been a growing recognition worldwide of the importance of managing dyslipidemia for the primary and secondary prevention of atherosclerotic vascular disease, especially coronary heart disease. This has been mainly due to the publication of the guidelines of National Cholesterol Education Program’s Adult Treatment Panel and Pediatric Panel from the United States. These guidelines have stimulated generation of similar recommendations from all over the world, particularly Europe, Canada, Australia and Asia.  Developed by a renowned group of leading international experts, the book offers state-of-the-art chapters that are peer-reviewed and represent a comprehensive assessment of the field.  A major addition to the literature, Dyslipidemias: Pathophysiology, Evaluation and Management is a gold-standard level reference for all clinicians who are challenged to provide the best care and new opportunities for patients with dyslipidemias.

Keywords

Abetalipoproteinemia Chronic kidney disease Drug-induced dyslipidemia Dyslipidemia Familial lipodystrophies Genetic disorders of HDL metabolism Genetic hypobetalipoproteinemia Lipoprotein Monogenic hypercholesterolemia Monogenic hypertriglyceridemia Nutritional therapy Phytosterol therapy Polygenic dyslipidemia Sitosterolemia Type 1 diabetes Type 2 diabetes Type III dyslipidemia

Editors and affiliations

  • Abhimanyu Garg
    • 1
  1. 1.Professor of Internal MedicineUT Southwestern Medical CenterDallasUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-60761-424-1
  • Copyright Information Humana Press 2015
  • Publisher Name Humana Press, Totowa, NJ
  • eBook Packages Medicine
  • Print ISBN 978-1-60761-423-4
  • Online ISBN 978-1-60761-424-1
  • About this book